Cowen analyst Ritu Baral was out with a favorable note on shares of Sangamo Biosciences, Inc. (NASDAQ:SGMO), after the biotech company released second-quarter results and provided …
Sangamo BioSciences (NASDAQ:SGMO) was founded in 1995 ostensibly to commercialize zinc finger nuclease technology. Twenty years have passed since its founding and there …
In a research note published yesterday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on Sangamo BioSciences (NASDAQ:SGMO) and raised her price target …